Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityActive in the last 2 years

Hongchun Guo

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5108083191. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2012: 4 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 6

  1. [Retracted] Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P‑glycoprotein and MRPs expression. Co-author DOI 10.3892/ol.2024.14568↗
  2. Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P-glycoprotein and MRPs expression. Co-author DOI 10.3892/ol.2020.12030↗
  3. Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis. Co-author DOI 10.1371/journal.pone.0042146↗
  4. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro. Co-author DOI 10.3892/ijo.2011.1285↗
  5. Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway. Co-author DOI 10.3892/ijo.2012.1519↗
  6. Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway. Co-author DOI 10.7150/ijbs.8.1↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tao Xue · 2 shared papers, 2020–2024 · strength 0.47
  2. Zhaohong Wang · 3 shared papers, 2012 · strength 0.09
  3. Sheng‐Zhang Lin · 3 shared papers, 2012 · strength 0.09
  4. Hongfei Tong · 3 shared papers, 2012 · strength 0.09
  5. Dian-Lei Liu · 3 shared papers, 2012 · strength 0.09
  6. Heqi Bu · 2 shared papers, 2012 · strength 0.06
  7. Weitian Wei · 2 shared papers, 2012 · strength 0.06
  8. Jian-Hong Zhang · 1 shared paper, 2012 · strength 0.03
  9. Shengzhang Lin · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.